AgomAb Therapeutics NV (AGMB)
10.51
-0.05
(-0.47%)
USD |
NASDAQ |
May 19, 16:00
10.50
-0.02
(-0.14%)
After-Hours: 20:00
AgomAb Therapeutics Market Cap : 517.60M for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| UCB SA | 51.68B |
| AstraZeneca PLC | 286.35B |
| ANI Pharmaceuticals, Inc. | 1.826B |
| Corcept Therapeutics, Inc. | 6.250B |
| Assertio Holdings, Inc. | 150.22M |
Market Cap Related Metrics
| Price to Book Value | 3.367 |
| Price | 10.51 |
| Earnings Yield | -6.40% |